abobotulinumtoxinA
Oxybutynin may increase the anticholinergic activities of Botulinum Toxin Type A.
Acetyl Sulfisoxazole
The metabolism of Oxybutynin can be decreased when combined with Acetyl sulfisoxazole.
Aclidinium
Oxybutynin may increase the anticholinergic activities of Aclidinium.
Advertisement
Alfentanil
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Alfentanil.
Alphaprodine
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Alphaprodine.
Ambenonium
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Ambenonium.
Advertisement
Amiodarone
The serum concentration of Oxybutynin can be increased when it is combined with Amiodarone.
Amodiaquine
The serum concentration of Amodiaquine can be increased when it is combined with Oxybutynin.
Apalutamide
The serum concentration of Oxybutynin can be decreased when it is combined with Apalutamide.
Advertisement
Aprepitant
The serum concentration of Oxybutynin can be increased when it is combined with Aprepitant.
Asunaprevir
The serum concentration of Asunaprevir can be increased when it is combined with Oxybutynin.
Atazanavir
The serum concentration of Oxybutynin can be increased when it is combined with Atazanavir.
Atomoxetine
The metabolism of Oxybutynin can be decreased when combined with Atomoxetine.
Atorvastatin
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Atorvastatin.
Atracurium
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Atracurium.
Atracurium Besylate
The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Oxybutynin.
Atropine
The risk or severity of adverse effects can be increased when Atropine is combined with Oxybutynin.
Benactyzine
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Benactyzine.
Bendroflumethiazide
The serum concentration of Bendroflumethiazide can be increased when it is combined with Oxybutynin.
Benzthiazide
The serum concentration of Benzthiazide can be increased when it is combined with Oxybutynin.
Benztropine
The risk or severity of adverse effects can be increased when Benzatropine is combined with Oxybutynin.
Biperiden
The risk or severity of adverse effects can be increased when Biperiden is combined with Oxybutynin.
Boceprevir
The serum concentration of Oxybutynin can be increased when it is combined with Boceprevir.
Bortezomib
The metabolism of Oxybutynin can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Oxybutynin can be decreased when it is combined with Bosentan.
Bosentan Anhydrous
The serum concentration of Oxybutynin can be decreased when it is combined with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Oxybutynin.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Oxybutynin.
Botulinum Toxin Type A
Oxybutynin may increase the anticholinergic activities of Botulinum Toxin Type A.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Oxybutynin.
Buprenorphine
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Buprenorphine.
Butorphanol
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Butorphanol.
Butylscopolamine
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Butylscopolamine.
Cabergoline
The risk or severity of adverse effects can be increased when Cabergoline is combined with Oxybutynin.
Carbamazepine
The metabolism of Oxybutynin can be increased when combined with Carbamazepine.
Ceritinib
The serum concentration of Oxybutynin can be increased when it is combined with Ceritinib.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Oxybutynin.
Chlorothiazide
The serum concentration of Chlorothiazide can be increased when it is combined with Oxybutynin.
Chlorphenoxamine
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Chlorphenoxamine.
Chlorthalidone
The serum concentration of Chlorthalidone can be increased when it is combined with Oxybutynin.
Clarithromycin
The serum concentration of Oxybutynin can be increased when it is combined with Clarithromycin.
Clemastine
The metabolism of Oxybutynin can be decreased when combined with Clemastine.
Clotrimazole
The metabolism of Oxybutynin can be decreased when combined with Clotrimazole.
Cobicistat
The serum concentration of Oxybutynin can be increased when it is combined with Cobicistat.
Codeine
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Codeine.
Codeine Anhydrous
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Codeine.
CODEINE POLISTIREX
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Codeine.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Oxybutynin.
Crizotinib
The metabolism of Oxybutynin can be decreased when combined with Crizotinib.
Curcumin
The serum concentration of Oxybutynin can be increased when it is combined with Curcumin.
Cyclopenthiazide
The serum concentration of Cyclopenthiazide can be increased when it is combined with Oxybutynin.
Cyclopentolate
The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Oxybutynin.
Cyclosporine
The metabolism of Oxybutynin can be decreased when combined with Cyclosporine.
Dabrafenib
The serum concentration of Oxybutynin can be decreased when it is combined with Dabrafenib.
Darifenacin
The risk or severity of adverse effects can be increased when Darifenacin is combined with Oxybutynin.
Darunavir
The serum concentration of Oxybutynin can be increased when it is combined with Darunavir.
Dasatinib
The serum concentration of Oxybutynin can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Oxybutynin can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Oxybutynin can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Oxybutynin can be decreased when combined with Delavirdine.
Demecarium
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Demecarium.
Desloratadine
The risk or severity of adverse effects can be increased when Desloratadine is combined with Oxybutynin.
Dexetimide
The risk or severity of adverse effects can be increased when Dexetimide is combined with Oxybutynin.
Dextromoramide
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Dextromoramide.
Dezocine
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Dezocine.
Dicyclomine
The risk or severity of adverse effects can be increased when Dicyclomine is combined with Oxybutynin.
Dihydrocodeine
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Dihydrocodeine.
Dihydroergocornine
The risk or severity of adverse effects can be increased when Dihydroergocornine is combined with Oxybutynin.
Dihydroergocristine
The risk or severity of adverse effects can be increased when Dihydroergocristine is combined with Oxybutynin.
Dihydroergotamine
The risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Oxybutynin.
Diltiazem
The metabolism of Oxybutynin can be decreased when combined with Diltiazem.
Diphenhydramine
The risk or severity of adverse effects can be increased when Diphenhydramine is combined with Oxybutynin.
Diphenoxylate
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Diphenoxylate.
Dipivefrin
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Dipivefrin.
Distigmine
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Distigmine.
Donepezil
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Donepezil.
Doxycycline
The metabolism of Oxybutynin can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Oxybutynin can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Oxybutynin can be decreased when combined with Dronedarone.
Echothiophate
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Echothiophate.
Edrophonium
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Edrophonium.
Eluxadoline
Oxybutynin may increase the constipating activities of Eluxadoline.
Enzalutamide
The serum concentration of Oxybutynin can be decreased when it is combined with Enzalutamide.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Oxybutynin.
Ergotamine
The risk or severity of adverse effects can be increased when Ergotamine is combined with Oxybutynin.
Erythromycin
The metabolism of Oxybutynin can be decreased when combined with Erythromycin.
Ethanol
Ethanol may increase the central nervous system depressant (CNS depressant) activities of Oxybutynin.
Ethylmorphine
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Ethylmorphine.
Fentanyl
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Fentanyl.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Oxybutynin.
Flavoxate
The risk or severity of adverse effects can be increased when Flavoxate is combined with Oxybutynin.
Flavoxate Hydrochloride
The risk or severity of adverse effects can be increased when Flavoxate is combined with Oxybutynin.
Fluconazole
The metabolism of Oxybutynin can be decreased when combined with Fluconazole.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Oxybutynin.
Fluvoxamine
The metabolism of Oxybutynin can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Oxybutynin can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Oxybutynin can be increased when it is combined with Fosaprepitant.
Fosphenytoin
The metabolism of Oxybutynin can be increased when combined with Fosphenytoin.
Fusidate
The serum concentration of Oxybutynin can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Oxybutynin can be increased when it is combined with Fusidic Acid.
Galantamine
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Galantamine.
Gallamine Triethiodide
The risk or severity of adverse effects can be increased when Gallamine Triethiodide is combined with Oxybutynin.
Ginkgo biloba extract
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Ginkgo biloba.
Glucagon
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Glucagon recombinant.
glucagon (rDNA)
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Glucagon recombinant.
Glycopyrronium
Oxybutynin may increase the anticholinergic activities of Glycopyrronium.
Heroin
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Heroin.
Homatropine
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Homatropine.
Human Secretin
The therapeutic efficacy of Human secretin can be decreased when used in combination with Oxybutynin.
Hydrochlorothiazide
The serum concentration of Hydrochlorothiazide can be increased when it is combined with Oxybutynin.
Hydrocodone
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Hydrocodone.
HYDROCODONE POLISTIREX
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Hydrocodone.
Hydroflumethiazide
The serum concentration of Hydroflumethiazide can be increased when it is combined with Oxybutynin.
Hydromorphone
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Hydromorphone.
Hyoscyamine
The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Oxybutynin.
Hypoxis hemerocallidea root extract
The serum concentration of Oxybutynin can be decreased when it is combined with St. John's Wort.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Oxybutynin.
Idelalisib
The serum concentration of Oxybutynin can be increased when it is combined with Idelalisib.
Imatinib
The metabolism of Oxybutynin can be decreased when combined with Imatinib.
incobotulinumtoxinA
Oxybutynin may increase the anticholinergic activities of Botulinum Toxin Type A.
Indapamide
The serum concentration of Indapamide can be increased when it is combined with Oxybutynin.
Indinavir
The serum concentration of Oxybutynin can be increased when it is combined with Indinavir.
INDINAVIR ANHYDROUS
The serum concentration of Oxybutynin can be increased when it is combined with Indinavir.
Ipratropium
The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Oxybutynin.
Ipratropium cation
The risk or severity of adverse effects can be increased when Ipratropium bromide is combined with Oxybutynin.
Isavuconazole
The serum concentration of Oxybutynin can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Oxybutynin can be decreased when combined with Isavuconazonium.
Isoflurophate
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Isoflurophate.
Isradipine
The metabolism of Oxybutynin can be decreased when combined with Isradipine.
Itraconazole
The serum concentration of Oxybutynin can be increased when it is combined with Itraconazole.
Ivacaftor
The serum concentration of Oxybutynin can be increased when it is combined with Ivacaftor.
Ketoconazole
The serum concentration of Oxybutynin can be increased when it is combined with Ketoconazole.
Levomethadyl
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Levomethadyl Acetate.
Levorphanol
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Levorphanol.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Oxybutynin.
Lopinavir
The serum concentration of Oxybutynin can be increased when it is combined with Lopinavir.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Oxybutynin.
Luliconazole
The serum concentration of Oxybutynin can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Oxybutynin can be increased when combined with Lumacaftor.
Malathion
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Malathion.
Mecamylamine
The risk or severity of adverse effects can be increased when Mecamylamine is combined with Oxybutynin.
Mefloquine
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Mefloquine.
Memantine
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Memantine.
Meperidine
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Pethidine.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Oxybutynin.
Methadone
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Methadone.
Methadyl Acetate
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Methadyl Acetate.
Methantheline
The risk or severity of adverse effects can be increased when Methantheline is combined with Oxybutynin.
Methixene
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Metixene.
Methscopolamine
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Methscopolamine.
Methscopolamine Bromide
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Methylscopolamine bromide.
Methyclothiazide
The serum concentration of Methyclothiazide can be increased when it is combined with Oxybutynin.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Oxybutynin.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Oxybutynin.
Metoclopramide
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Metoclopramide.
Metolazone
The serum concentration of Metolazone can be increased when it is combined with Oxybutynin.
Metoprolol
The serum concentration of Metoprolol can be increased when it is combined with Oxybutynin.
Mianserin
Mianserin may increase the anticholinergic activities of Oxybutynin.
Mifepristone
The serum concentration of Oxybutynin can be increased when it is combined with Mifepristone.
Minaprine
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Minaprine.
Mirabegron
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Mirabegron.
Mitotane
The serum concentration of Oxybutynin can be decreased when it is combined with Mitotane.
Morphine
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Morphine.
Nabilone
Oxybutynin may increase the tachycardic activities of Nabilone.
Nalbuphine
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Nalbuphine.
Nefazodone
The serum concentration of Oxybutynin can be increased when it is combined with Nefazodone.
Nelfinavir
The serum concentration of Oxybutynin can be increased when it is combined with Nelfinavir.
Neostigmine
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Neostigmine.
Netupitant
The serum concentration of Oxybutynin can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Oxybutynin can be increased when combined with Nevirapine.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Oxybutynin.
Nilotinib
The metabolism of Oxybutynin can be decreased when combined with Nilotinib.
Normethadone
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Normethadone.
O-PHENANTHROLINE
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with 1,10-Phenanthroline.
Octotropine Methylbromide
The risk or severity of adverse effects can be increased when Anisotropine Methylbromide is combined with Oxybutynin.
Octylonium
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Otilonium.
Olaparib
The metabolism of Oxybutynin can be decreased when combined with Olaparib.
onabotulinumtoxinA
Oxybutynin may increase the anticholinergic activities of Botulinum Toxin Type A.
Opium
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Opium.
Orphenadrine
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Orphenadrine.
Osimertinib
The serum concentration of Oxybutynin can be increased when it is combined with Osimertinib.
Oxitropium
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Oxitropium.
Oxycodone
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Oxycodone.
Oxymorphone
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Oxymorphone.
Oxyphenonium
The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Oxybutynin.
Palbociclib
The serum concentration of Oxybutynin can be increased when it is combined with Palbociclib.
Pancuronium
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Pancuronium.
Pancuronium Bromide
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Pancuronium.
Paregoric
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Morphine.
Pentazocine
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Pentazocine.
Pentobarbital
The metabolism of Oxybutynin can be increased when combined with Pentobarbital.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Oxybutynin.
Phenobarbital
The metabolism of Oxybutynin can be increased when combined with Phenobarbital.
Phenytoin
The metabolism of Oxybutynin can be increased when combined with Phenytoin.
Physostigmine
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Physostigmine.
Pipecuronium
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Pipecuronium.
Pirenzepine
The risk or severity of adverse effects can be increased when Pirenzepine is combined with Oxybutynin.
Pirinitramide
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Piritramide.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Oxybutynin.
Polythiazide
The serum concentration of Polythiazide can be increased when it is combined with Oxybutynin.
Posaconazole
The serum concentration of Oxybutynin can be increased when it is combined with Posaconazole.
Potassium Chloride
Oxybutynin may increase the ulcerogenic activities of Potassium Chloride.
Pramlintide
Pramlintide may increase the anticholinergic activities of Oxybutynin.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Oxybutynin.
Primidone
The metabolism of Oxybutynin can be increased when combined with Primidone.
Procyclidine
The risk or severity of adverse effects can be increased when Procyclidine is combined with Oxybutynin.
Profenamine
The risk or severity of adverse effects can be increased when Ethopropazine is combined with Oxybutynin.
Propantheline
The risk or severity of adverse effects can be increased when Propantheline is combined with Oxybutynin.
Propantheline Bromide
The risk or severity of adverse effects can be increased when Propantheline is combined with Oxybutynin.
Propiverine
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Propiverine.
Propoxyphene
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Dextropropoxyphene.
Pyridostigmine
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Pyridostigmine.
Pyridostigmine Bromide
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Pyridostigmine.
Quinethazone
The serum concentration of Quinethazone can be increased when it is combined with Oxybutynin.
Quinidine
The risk or severity of adverse effects can be increased when Quinidine is combined with Oxybutynin.
Ranolazine
The metabolism of Oxybutynin can be decreased when combined with Ranolazine.
Remifentanil
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Remifentanil.
Rifabutin
The metabolism of Oxybutynin can be increased when combined with Rifabutin.
Rifampin
The metabolism of Oxybutynin can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Oxybutynin can be increased when combined with Rifapentine.
Rilpivirine
The serum concentration of Rilpivirine can be increased when it is combined with Oxybutynin.
rimabotulinumtoxinB
Oxybutynin may increase the anticholinergic activities of Botulinum Toxin Type B.
Rivastigmine
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Rivastigmine.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Oxybutynin.
Rucaparib
The metabolism of Oxybutynin can be decreased when combined with Rucaparib.
Saquinavir
The serum concentration of Oxybutynin can be increased when it is combined with Saquinavir.
Saquinavir Mesylate
The serum concentration of Oxybutynin can be increased when it is combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Sarilumab.
Scopolamine
The risk or severity of adverse effects can be increased when Scopolamine is combined with Oxybutynin.
Scopolamine Hydrobromide
The risk or severity of adverse effects can be increased when Scopolamine is combined with Oxybutynin.
Secretin
The therapeutic efficacy of Secretin can be decreased when used in combination with Oxybutynin.
Sildenafil
The metabolism of Oxybutynin can be decreased when combined with Sildenafil.
Siltuximab
The serum concentration of Oxybutynin can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Oxybutynin can be increased when it is combined with Simeprevir.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Oxybutynin.
Solifenacin
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Solifenacin.
ST. JOHN'S WORT EXTRACT
The serum concentration of Oxybutynin can be decreased when it is combined with St. John's Wort.
Sufentanil
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Sufentanil.
Sulfisoxazole
The metabolism of Oxybutynin can be decreased when combined with Sulfisoxazole.
Sulpiride
Oxybutynin may increase the anticholinergic activities of Sulpiride.
Tacrine
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Tacrine.
Tapentadol
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Tapentadol.
Telaprevir
The serum concentration of Oxybutynin can be increased when it is combined with Telaprevir.
Telithromycin
The serum concentration of Oxybutynin can be increased when it is combined with Telithromycin.
Tetrahydrocannabinol
Oxybutynin may increase the tachycardic activities of Dronabinol.
Thioridazine
The serum concentration of Thioridazine can be increased when it is combined with Oxybutynin.
Ticlopidine
The metabolism of Oxybutynin can be decreased when combined with Ticlopidine.
Tiotropium
Oxybutynin may increase the anticholinergic activities of Tiotropium.
Tocilizumab
The serum concentration of Oxybutynin can be decreased when it is combined with Tocilizumab.
Tolterodine
The risk or severity of adverse effects can be increased when Tolterodine is combined with Oxybutynin.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Oxybutynin.
Topiramate
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Topiramate.
Tramadol
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Tramadol.
Trichlormethiazide
The serum concentration of Trichlormethiazide can be increased when it is combined with Oxybutynin.
Trihexyphenidyl
The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Oxybutynin.
Trihexyphenidyl Hydrochloride
The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Oxybutynin.
Trimethaphan
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Trimethaphan.
Tropicamide
The risk or severity of adverse effects can be increased when Tropicamide is combined with Oxybutynin.
Trospium
The risk or severity of adverse effects can be increased when Trospium is combined with Oxybutynin.
Tubocurarine
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Tubocurarine.
Tyrothricin
The therapeutic efficacy of Oxybutynin can be decreased when used in combination with Tyrothricin.
Umeclidinium
Oxybutynin may increase the anticholinergic activities of Umeclidinium.
Vecuronium
The risk or severity of adverse effects can be increased when Oxybutynin is combined with Vecuronium.
Vemurafenib
The serum concentration of Oxybutynin can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Oxybutynin can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Oxybutynin can be decreased when combined with Verapamil.
Voriconazole
The serum concentration of Oxybutynin can be increased when it is combined with Voriconazole.
Ziprasidone
The metabolism of Oxybutynin can be decreased when combined with Ziprasidone.
